REVVITY, INC Cash and Cash Equivalents
REVVITY, INC (RVTY) had Cash and Cash Equivalents of $1.02 billion as of 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-11
- 2026-07-05: Cash and Cash Equivalents, at Carrying Value $1.02B.
- 2026-04-05: Cash and Cash Equivalents, at Carrying Value $860.32M.
- 2025-12-28: Cash and Cash Equivalents, at Carrying Value $919.86M.
- 2025-09-28: Cash and Cash Equivalents, at Carrying Value $931.39M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-07-05 | $1.02B 10-Q · filed 2026-08-11 | |
| 2026-04-05 | $860.32M 10-Q · filed 2026-05-12 | |
| 2025-12-28 | $919.86M 10-Q · filed 2026-08-11 | |
| 2025-09-28 | $931.39M 10-Q · filed 2025-11-04 | |
| 2025-06-29 | $991.85M 10-Q · filed 2026-08-11 | |
| 2025-03-30 | $1.14B 10-Q · filed 2026-05-12 | |
| 2024-12-29 | $1.16B 10-K · filed 2026-02-24 | |
| 2024-09-29 | $1.23B 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.25B 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $998.08M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $913.16M 10-K · filed 2026-02-24 | |
| 2023-10-01 | $1.14B 10-Q · filed 2024-11-06 | |
| 2023-07-02 | $1.33B 10-Q · filed 2024-08-06 | |
| 2023-04-02 | $2.27B 10-Q · filed 2024-05-07 | |
| 2023-01-01 | $454.36M 10-K · filed 2025-02-25 | |
| 2022-10-02 | $400.74M 10-Q · filed 2023-11-07 | |
| 2022-07-03 | $345.86M 10-Q · filed 2023-08-09 | $360.86M 10-Q · filed 2022-08-09 |
| 2022-04-03 | $654.76M 10-Q · filed 2023-05-12 | $669.75M 10-Q · filed 2022-05-10 |
| 2022-01-02 | $603.32M 10-K · filed 2024-02-27 | $618.32M 10-K · filed 2022-03-03 |
| 2021-10-03 | $472.37M 10-Q · filed 2022-11-14 | $487.37M 10-Q · filed 2021-11-09 |
| 2021-07-04 | $572.81M 10-Q · filed 2022-08-09 | |
| 2021-04-04 | $988.23M 10-Q · filed 2022-05-10 | |
| 2021-01-03 | $387.05M 10-K · filed 2023-03-01 | $402.04M 10-K · filed 2021-03-02 |
| 2020-10-04 | $258.29M 10-Q · filed 2021-11-09 | |
| 2020-07-05 | $218.54M 10-Q · filed 2021-08-10 | |
| 2020-04-05 | $195.15M 10-Q · filed 2021-05-11 | |
| 2019-12-29 | $191.88M 10-K · filed 2022-03-03 | |
| 2019-09-29 | $392.97M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $150.02M 10-Q · filed 2020-08-11 | |
| 2019-03-31 | $134.25M 10-Q · filed 2020-05-12 | |
| 2018-12-30 | $163.11M 10-K · filed 2021-03-02 | |
| 2018-09-30 | $149.51M 10-Q · filed 2019-11-05 | |
| 2018-07-01 | $163.39M 10-Q · filed 2019-08-06 | |
| 2018-04-01 | $180.80M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $202.13M 10-K · filed 2020-02-25 | |
| 2017-10-01 | $709.49M 10-Q · filed 2018-11-06 | |
| 2017-07-02 | $616.31M 10-Q · filed 2018-08-07 | |
| 2017-04-02 | $288.33M 10-Q · filed 2018-05-08 | |
| 2017-01-01 | $359.26M 10-K · filed 2019-02-26 | |
| 2016-10-02 | $311.66M 10-Q · filed 2017-11-07 | |
| 2016-07-03 | $248.08M 10-Q · filed 2017-08-08 | |
| 2016-04-03 | $210.73M 10-Q · filed 2017-05-09 | |
| 2016-01-03 | $237.93M 10-K · filed 2018-02-27 | |
| 2015-10-04 | $195.07M 10-Q · filed 2016-11-08 | |
| 2015-06-28 | $192.17M 10-Q · filed 2016-08-09 | |
| 2015-03-29 | $168.92M 10-Q · filed 2016-05-10 | |
| 2014-12-28 | $174.82M 10-K · filed 2018-02-27 | |
| 2014-09-28 | $203.68M 10-Q · filed 2015-11-10 | |
| 2014-06-29 | $205.26M 10-Q · filed 2015-08-04 | |
| 2014-03-30 | $224.11M 10-Q · filed 2015-05-05 | |
| 2013-12-29 | $174.82M 10-K · filed 2017-02-28 | $173.24M 10-K · filed 2014-02-25 |
| 2013-09-29 | $132.30M 10-Q · filed 2014-11-04 | |
| 2013-06-30 | $112.47M 10-Q · filed 2014-08-05 | |
| 2013-03-31 | $125.87M 10-Q · filed 2014-05-06 | |
| 2012-12-30 | $173.24M 10-K · filed 2017-02-28 | $171.44M 10-K · filed 2013-02-26 |
| 2012-09-30 | $170.83M 10-Q · filed 2013-11-05 | |
| 2012-07-01 | $171.40M 10-Q · filed 2013-08-06 | |
| 2012-04-01 | $144.76M 10-Q · filed 2013-05-06 | |
| 2012-01-01 | $142.34M 10-K · filed 2015-02-24 | |
| 2011-10-02 | $248.10M 10-Q · filed 2012-11-06 | |
| 2011-07-03 | $395.21M 10-Q · filed 2012-08-07 | |
| 2011-04-03 | $415.85M 10-Q · filed 2012-05-08 | |
| 2011-01-02 | $420.09M 10-K · filed 2014-02-25 | |
| 2010-10-03 | $250.99M 10-Q · filed 2011-11-04 | |
| 2010-07-04 | $215.66M 10-Q · filed 2011-08-10 | |
| 2010-04-04 | $181.74M 10-Q · filed 2011-05-10 | |
| 2010-01-03 | $179.71M 10-K · filed 2013-02-26 | |
| 2009-10-04 | $150.59M 10-Q · filed 2010-11-10 | |
| 2009-07-05 | $151.34M 10-Q · filed 2010-08-10 | |
| 2008-12-28 | $179.11M 10-K · filed 2012-02-28 | |
| 2007-12-30 | $203.35M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |